Cargando…
Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer
BACKGROUND: The gastrin releasing peptide receptor (GRPR) and the somatostatin receptor 2 (SSTR2) are overexpressed on primary breast cancer (BC), making them ideal candidates for receptor-mediated nuclear imaging and therapy. The aim of this study was to determine whether these receptors are also s...
Autores principales: | Dalm, Simone U., Schrijver, Willemijne A. M. E., Sieuwerts, Anieta M., Look, Maxime P., Ziel - van der Made, Angelique C. J., de Weerd, Vanja, Martens, John W., van Diest, Paul J., de Jong, Marion, van Deurzen, Carolien H. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5249060/ https://www.ncbi.nlm.nih.gov/pubmed/28107508 http://dx.doi.org/10.1371/journal.pone.0170536 |
Ejemplares similares
-
Progressive APOBEC3B mRNA expression in distant breast cancer metastases
por: Sieuwerts, Anieta M., et al.
Publicado: (2017) -
Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: an independent retrospective validation study
por: Sieuwerts, Anieta M, et al.
Publicado: (2010) -
APOBEC3B Gene Expression in Ductal Carcinoma In Situ and Synchronous Invasive Breast Cancer
por: Sieuwerts, Anieta M., et al.
Publicado: (2019) -
H3-receptor regulation of vascular gastrin and somatostatin releases by the isolated rat stomach.
por: Bado, A., et al.
Publicado: (1994) -
High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes
por: Riaz, Muhammad, et al.
Publicado: (2012)